Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.69B |
| 2 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.32B |
| 3 |
Vanguard Total Bond Market
BND
|
+$1.21B |
| 4 |
SPDR Gold Trust
GLD
|
+$970M |
| 5 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$842M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.66B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$5.23B |
| 3 |
Accenture
ACN
|
+$1.14B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.13B |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$635M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.44% |
| 2 | Financials | 11.14% |
| 3 | Consumer Discretionary | 8.06% |
| 4 | Healthcare | 8.02% |
| 5 | Communication Services | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
RXO
RXO
$3.85B
| $28M | ﹤0.01% |
2,211,797
+521,428
| +31% | +$7.69M |
|
2627
Pediatrix Medical
MD
$2.14B
| $27.9M | ﹤0.01% |
1,304,070
+24,659
| +2% | +$505K |
|
2628
BOK Financial
BOKF
$8.85B
| $27.8M | ﹤0.01% |
235,096
+51,342
| +28% | +$5.76M |
|
|
CNTA
2629
DELISTED
Centessa Pharmaceuticals
CNTA
| $27.7M | ﹤0.01% |
1,109,098
-15,347
| -1% | -$389K |
|
2630
Pagaya Technologies
PGY
$1.79B
| $27.7M | ﹤0.01% |
1,326,266
+194,762
| +17% | +$4.96M |
|
|
RMT
2631
Royce Micro-Cap Trust
RMT
$780M
| $27.7M | ﹤0.01% |
2,652,412
+70,439
| +3% | +$732K |
|
2632
First Financial Bancorp
FFBC
$3.6B
| $27.6M | ﹤0.01% |
1,104,790
+35,422
| +3% | +$884K |
|
2633
Establishment Labs
ESTA
$2.25B
| $27.6M | ﹤0.01% |
378,448
-460,016
| -55% | -$27.8M |
|
2634
PIMCO 1-5 Year US TIPS Index Exchange-Traded Fund
STPZ
$525M
| $27.5M | ﹤0.01% |
513,365
-63,564
| -11% | -$3.43M |
|
2635
Twist Bioscience
TWST
$7.86B
| $27.5M | ﹤0.01% |
866,356
-625,750
| -42% | -$19.5M |
|
2636
Corvus Pharmaceuticals
CRVS
$1.27B
| $27.5M | ﹤0.01% |
3,567,908
+2,950,684
| +478% | +$23.3M |
|
|
WAY
2637
Waystar Holding Corp
WAY
$4.81B
| $27.5M | ﹤0.01% |
838,814
-140,711
| -14% | -$5.01M |
|
2638
Compass
COMP
$10.2B
| $27.4M | ﹤0.01% |
2,596,079
-1,626,703
| -39% | -$14.8M |
|
2639
Brady Corp
BRC
$4.43B
| $27.4M | ﹤0.01% |
349,957
+31,881
| +10% | +$2.47M |
|
2640
Provident Financial Services
PFS
$3.26B
| $27.3M | ﹤0.01% |
1,381,795
-16,410
| -1% | -$317K |
|
2641
Nuveen ESG International Developed Markets Equity ETF
NUDM
$730M
| $27.2M | ﹤0.01% |
752,029
+71,826
| +11% | +$2.72M |
|
2642
Century Communities
CCS
$2.04B
| $27.1M | ﹤0.01% |
457,020
+67,884
| +17% | +$4.13M |
|
2643
JPMorgan BetaBuilders Europe ETF
BBEU
$9.53B
| $27.1M | ﹤0.01% |
369,495
-34,131
| -8% | -$2.43M |
|
2644
iShares International Equity Factor ETF
INTF
$3.77B
| $27.1M | ﹤0.01% |
716,912
-22,894
| -3% | -$841K |
|
2645
PENN Entertainment
PENN
$2.53B
| $27M | ﹤0.01% |
1,831,931
+43,461
| +2% | +$678K |
|
2646
Synaptics
SYNA
$4.2B
| $27M | ﹤0.01% |
364,846
+60,377
| +20% | +$4.24M |
|
2647
Cogent Communications
CCOI
$530M
| $27M | ﹤0.01% |
1,252,451
-548,082
| -30% | -$16.2M |
|
2648
Cimpress
CMPR
$2.37B
| $27M | ﹤0.01% |
405,127
-50,058
| -11% | -$3.4M |
|
2649
LegalZoom.com
LZ
$993M
| $27M | ﹤0.01% |
2,715,356
+520,777
| +24% | +$5.16M |
|
2650
First Trust Consumer Staples AlphaDEX Fund
FXG
$232M
| $26.9M | ﹤0.01% |
444,087
-69,105
| -13% | -$4.28M |
|
Similar funds
Morgan Stanley's Q4 2025 Portfolio in Review
As of Q4 2025, Morgan Stanley held 8,587 positions worth $1.67T, up 1.4% from $1.65T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Morgan Stanley's Q4 2025 filing shows 427 new, 3,946 increased, 2,962 reduced and 384 closed positions. Its largest new stake was Medline Inc: 15,162,060 shares worth $637M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $7.66B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q4 2025 buy was Medline Inc: 15,162,060 shares worth $637M.
- Morgan Stanley added most to Vanguard FTSE Developed Markets ETF in Q4 2025, an estimated $1.69B increase.
- Morgan Stanley's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.66B.
- Morgan Stanley fully exited Mr. Cooper in Q4 2025, selling an estimated $312M.
- Morgan Stanley's ten largest holdings make up 22% of its $1.67T portfolio in Q4 2025.
- Morgan Stanley opened 427 new positions and closed 384 in Q4 2025.
- Morgan Stanley's portfolio value rose 1.4% quarter-over-quarter to $1.67T.
Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.